Skip to main content

Perez Edith A.'s Form 4 filing

Bolt Biotherapeutics, Inc. (BOLT) · filed Feb 1, 2022

Accession no.
0000899243-22-003917
Filed
Feb 1, 2022
Trade date
Jun 4-Dec 22, 2021
Filing delay
242 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market purchases total $17.2K. It was filed 242 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Perez Edith A.CIK 0001821419Officer (Chief Medical Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 4, 2021Common StockPPurchaseAcquired+917$16.65+$15,268.05917Direct
Dec 6, 2021Common StockPPurchaseAcquired+411$4.64+$1,907.041,328Direct
Dec 22, 2021Common StockMOption exerciseAcquired+35,714$2.80+$99,999.237,042Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 22, 2021Common StockMOption exerciseDisposed−35,714$0.00$0189,286Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)